The latest study on Gastroesophageal Reflux Disease (GERD) Therapeutics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Gastroesophageal Reflux Disease (GERD) Therapeutics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Type Segment:
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Application Segment:
Heartburn
Acid reflux disorders
Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Regions (Countries):
The Gastroesophageal Reflux Disease (GERD) Therapeutics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Gastroesophageal Reflux Disease (GERD) Therapeutics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Gastroesophageal Reflux Disease (GERD) Therapeutics Market:
Gastroesophageal Reflux Disease (GERD) Therapeutics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Gastroesophageal Reflux Disease (GERD) Therapeutics Market status and future forecast.
To present the key Gastroesophageal Reflux Disease (GERD) Therapeutics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 Antacids
1.4.3 Pro-kinetic agents
1.4.4 H2 Receptor Blockers
1.4.5 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
1.5.2 Heartburn
1.5.3 Acid reflux disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2016-2027)
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Manufacturers
3.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Manufacturers (2020)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020)
5 United States
5.1 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
5.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in United States
5.3 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
5.4 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
6 Europe
6.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
6.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Europe
6.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
6.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
7 China
7.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
7.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in China
7.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
7.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
8 Japan
8.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
8.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Japan
8.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
8.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
9.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
9.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
10 India
10.1 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
10.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in India
10.3 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
10.4 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2020)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Central & South America
11.3 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
11.4 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
12.1.5 AstraZeneca Recent Development
12.2 Eisai
12.2.1 Eisai Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
12.2.5 Eisai Recent Development
12.3 GSK
12.3.1 GSK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
12.3.5 GSK Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
12.4.5 Takeda Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
12.5.5 Johnson & Johnson Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Gastroesophageal Reflux Disease (GERD) Therapeutics Key Market Segments
Table Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Covered
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type 2016-2027
Figure Antacids Figures
Table Key Players of Antacids
Figure Pro-kinetic agents Figures
Table Key Players of Pro-kinetic agents
Figure H2 Receptor Blockers Figures
Table Key Players of H2 Receptor Blockers
Figure Proton Pump Inhibitors (PPIs) Figures
Table Key Players of Proton Pump Inhibitors (PPIs)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application 2016-2027 (Million US$)
Figure Heartburn Case Studies
Figure Acid reflux disorders Case Studies
Figure Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2027 (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions 2016-2027 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions 2016-2020 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2016-2020
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2016-2020
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2020
Table Market Top Trends
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Manufacturers (2020) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Manufacturers (2020)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Manufacturers in 2020
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product/Solution/Service
Table Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Type (2016-2020)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2016-2020)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Application (2016-2020)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2016-2020)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application in 2020
Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table United States Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table United States Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Figure Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2020) (Million US$)
Table Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2020)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2020)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2020)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
Table AstraZeneca Recent Development
Table Eisai Company Details
Table Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)(Million US$)
Figure Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
Table Eisai Recent Development
Table GSK Company Details
Table GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)(Million US$)
Figure GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
Table GSK Recent Development
Table Takeda Company Details
Table Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)(Million US$)
Figure Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
Table Takeda Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2020)
Table Johnson & Johnson Recent Development
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Regions in 2027
Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product (2021-2027)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product in 2027
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2021-2027)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources